CPZ Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-17157
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (95%), Rat (97%). Backed by our 100% Guarantee.
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against Recombinant Protein corresponding to amino acids: SYPFDFSKHPQEEKMFSPTPDEKMFKLLSRAYADVHPMMMDRSENRCGGNFLKRGSIINGADWYSFTGGMSDFNY
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for CPZ Antibody
Immunocytochemistry/ Immunofluorescence: CPZ Antibody [NBP3-17157]
Immunocytochemistry/Immunofluorescence: CPZ Antibody [NBP3-17157] - Staining of human cell line RH-30 shows localization to plasma membrane.Applications for CPZ Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Immunocytochemistry/Immunofluorescence, PFA/Triton X-100 is recommended for fixation/permeabilization.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CPZ
Alternate Names
carboxypeptidase Z, EC 3.4.17, EC 3.4.17.-, EC 3.4.17.10, EC 3.4.17.3, MGC99682
Gene Symbol
CPZ
Additional CPZ Products
Product Documents for CPZ Antibody
Product Specific Notices for CPZ Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...